Genetic Screening In Cancer Care: Optimizing Drug Safety And Efficacy Using Personalized Medicine
New tools can predict deadly reactions to common cancer drugs, but adoption lags despite evidence.
Gene screenings hold disease clues, but unexplained anomalies often raise fears
Many genetic findings are ambiguous, leaving doctors uncertain about whether a particular variant is truly dangerous.
presented by
RCM Outsourcing: Balancing Human Expertise & Smart Technology
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
Invitae expanding gene panels well beyond cancer
Invitae's proposition with these new panels is to democratize the genetic panel screen - testing for deeply impactful disorders that stretch beyond cancer.